Topic Hub
19 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 19 of 19 clinical reviews.
Clinical guide to the dutasteride and estradiol HRT drug interaction. Covers pharmacokinetic and pharmacodynamic mechanisms, VTE risk overlap, severity rating, dose adjustments, and monitoring protocols.
Read clinical reviewBoard-reviewed guide to the dutasteride (Avodart) and acetaminophen drug interaction, covering CYP metabolism, hepatic safety, dose guidance, and clinical monitoring.
Read clinical reviewCan you take dutasteride (Avodart) with omeprazole or pantoprazole? A clinician-reviewed guide covering CYP3A4 metabolism, absorption effects, severity ratings, and dose-adjustment recommendations.
Read clinical reviewCan you take dutasteride (Avodart) with sildenafil? A physician-reviewed guide covering the pharmacokinetic and pharmacodynamic interaction profile, blood pressure monitoring, and dose-adjustment protocols.
Read clinical reviewCan you take dutasteride (Avodart) with SNRIs like venlafaxine or duloxetine? Review of CYP3A4 pharmacokinetics, serotonin and blood pressure considerations, monitoring protocols, and dose-adjustment guidance.
Read clinical reviewEvidence-based review of the dutasteride and apixaban drug interaction, including CYP3A4/P-gp mechanism, severity rating, monitoring labs, dose adjustments, and patient counseling.
Read clinical reviewBoard-reviewed guide on the dutasteride and benzodiazepines interaction, covering CYP3A4 metabolism overlap, clinical severity, monitoring, and dose-adjustment recommendations.
Read clinical reviewIs it safe to take dutasteride (Avodart) with clopidogrel (Plavix)? A clinician-level review of CYP metabolism, DDI severity ratings, monitoring guidance, and surgical considerations for BPH patients on antiplatelet therapy.
Read clinical reviewCan you take dutasteride with hormonal contraceptives? Review the pharmacokinetic and pharmacodynamic interaction profile, clinical risks, CYP3A4 overlap, and monitoring recommendations.
Read clinical reviewIs it safe to take dutasteride (Avodart) with metformin? A physician-reviewed guide covering CYP metabolism, clinical evidence, monitoring protocols, and dose-adjustment considerations.
Read clinical reviewCan you take Avodart with ibuprofen or naproxen? A physician-reviewed guide to the dutasteride-NSAID interaction covering pharmacology, bleeding risk, renal effects, and clinical monitoring.
Read clinical reviewCan you take Avodart with oxycodone, hydrocodone, or tramadol? A physician-reviewed guide to the dutasteride-opioid interaction covering CYP metabolism, severity ratings, dose adjustment, and monitoring.
Read clinical reviewBoard-reviewed guide to combining dutasteride (Avodart) with testosterone replacement therapy. Covers pharmacodynamic mechanism, polycythemia risk, lipid effects, PSA interpretation, and monitoring protocols.
Read clinical reviewA clinical review of the dutasteride-trazodone drug interaction covering CYP3A4 metabolism, pharmacodynamic overlap, severity grading, monitoring parameters, and dose-adjustment guidance.
Read clinical reviewEvidence-based analysis of the dutasteride-warfarin drug interaction, covering CYP metabolism, bleeding risk, INR monitoring protocols, and practical prescribing considerations.
Read clinical reviewCan you take Avodart (dutasteride) with diphenhydramine? A clinician-level review of pharmacokinetic and pharmacodynamic interactions, risk severity, monitoring parameters, and patient counseling.
Read clinical reviewCan you take Avodart (dutasteride) with gabapentin? A physician-reviewed guide covering mechanism, severity, monitoring, dose adjustment, and patient counseling for this drug combination.
Read clinical reviewBoard-reviewed guide to combining dutasteride (Avodart) and rosuvastatin. Covers CYP3A4 vs. OATP metabolism, clinical risk, dose adjustments, and monitoring labs.
Read clinical reviewCan you take Avodart (dutasteride) with tadalafil? A physician-reviewed guide covering pharmacokinetic mechanisms, safety data from the CombAT trial, monitoring parameters, and dose adjustments.
Read clinical review